Furthermore, the high CNIH4 expression group in LIHC, pancreatic adenocarcinoma (PAAD), and THYM exhibited decreased activity in the RAS-MAPK and Receptor Tyrosine Kinase (RTK) pathways (Figure 4D). Here, NTRK1 is linked to pancreatic adenocarcinoma.